Genmab | GEN - Debt


Genmab reported DKK148M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Agios Pharmaceuticals USD 44.52M 4.24M Sep/2025
Almirall EUR 342.86M 61.94M Dec/2025
Amarin USD 0 0 Mar/2025
Amgen USD 54.59B 1.62B Sep/2025
argenx SE USD 43.15M 4.1M Jun/2025
AstraZeneca USD 32.63B 207M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
BioMarin Pharmaceutical USD 604.24M 375K Sep/2025
Demant DKK 20.99B 4.81B Dec/2025
Exelixis USD 176.46M 3.38M Sep/2025
Fresenius Medical Care EUR 10.8B 322.94M Dec/2025
Galapagos EUR 7.5M 3.36M Sep/2025
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
GN Store Nord DKK 11.79B 15M Jun/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Insmed USD 727.89M 163.33M Dec/2025
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 12.1B 2.7B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
UCB EUR 3.03B 12M Dec/2024